These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30849081)

  • 1. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
    Rakotonjanahary J; Gravier N; Lambron J; De Carli E; Toulgoat F; Delion M; Pellier I; Rialland X
    PLoS One; 2019; 14(3):e0212107. PubMed ID: 30849081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
    Rakotonjanahary J; De Carli E; Delion M; Kalifa C; Grill J; Doz F; Leblond P; Bertozzi AI; Rialland X;
    PLoS One; 2015; 10(6):e0127676. PubMed ID: 26098902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
    Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
    Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
    Kelly JP; Leary S; Khanna P; Weiss AH
    Ophthalmology; 2012 Jun; 119(6):1231-7. PubMed ID: 22364864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.
    Fisher MJ; Loguidice M; Gutmann DH; Listernick R; Ferner RE; Ullrich NJ; Packer RJ; Tabori U; Hoffman RO; Ardern-Holmes SL; Hummel TR; Hargrave DR; Bouffet E; Charrow J; Bilaniuk LT; Balcer LJ; Liu GT
    Neuro Oncol; 2012 Jun; 14(6):790-7. PubMed ID: 22474213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M; Opocher E; Viscardi E; Calderone M; Severino SM; Cermakova I; Perilongo G
    Pediatr Blood Cancer; 2010 Dec; 55(6):1083-8. PubMed ID: 20979170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
    Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
    J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
    de Blank PM; Berman JI; Liu GT; Roberts TP; Fisher MJ
    Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEUROFIBROMATOSIS TYPE 1 AND OPTIC PATHWAY GLIOMA.
    Siwá A; Autrata R; Vejmělková K; Pavelka Z; Zitterbart K
    Cesk Slov Oftalmol; 2019; 75(4):200-208. PubMed ID: 32397722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence.
    Moreno L; Bautista F; Ashley S; Duncan C; Zacharoulis S
    Eur J Cancer; 2010 Aug; 46(12):2253-9. PubMed ID: 20400294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
    Gnekow AK; Kortmann RD; Pietsch T; Emser A
    Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term visual outcome following chemoreduction for retinoblastoma.
    Demirci H; Shields CL; Meadows AT; Shields JA
    Arch Ophthalmol; 2005 Nov; 123(11):1525-30. PubMed ID: 16286614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term visual acuity outcomes after radiation therapy for sporadic optic pathway glioma.
    Acharya S; Quesada S; Coca K; Richardson C; Hoehn ME; Chiang J; Qaddoumi I; Boop FA; Gajjar A; Merchant TE
    J Neurooncol; 2019 Sep; 144(3):603-610. PubMed ID: 31414376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma.
    Narang S; Mashayekhi A; Rudich D; Shields CL
    Clin Exp Ophthalmol; 2012; 40(7):736-42. PubMed ID: 22300311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.